Decheng Capital LLC quarter change: USA Other Stocks, Unchanged
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, Decheng Capital LLC opened 0 positions, added to 0, reduced 0, sold out of 0 and left 1 unchanged. The largest increase in value was Lyell Immunopharma, Inc. (-$4,159,220); the largest decrease was Lyell Immunopharma, Inc. (-$4,159,220).
- Lyell Immunopharma, Inc.: Country of operation United States; Class COM; Shares 2026-03-31 692,050; Shares 2026-06-30 692,050.
Two Form 13F-HR filings compared (SEC CIK 2010850): 2026-03-31 (filed 2026-05-13) and 2026-06-30 (filed 2026-08-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Triasima Portfolio Management inc. | Canada | $0.661B | 137 |
| Fulcrum Asset Management LLP | United Kingdom | $0.662B | 220 |
| Optas, LLC | United States | $0.661B | 1,034 |
| GLOBEFLEX CAPITAL L P | United States | $0.661B | 387 |
| Heritage Investment Group, Inc. | United States | $0.661B | 123 |
| REGATTA CAPITAL GROUP, LLC | United States | $0.661B | 215 |
| Freemont Management S.A. | Switzerland | $0.661B | 136 |
| AFFINITY WEALTH MANAGEMENT LLC | United States | $0.661B | 103 |
| Arosa Capital Management LP | United States | $0.660B | 68 |
| Artemis Wealth Advisors, LLC | United States | $0.662B | 45 |